PTK6
Protein-tyrosine kinase 6
Also known as: BRK, PTK6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13882
- Gene
- PTK6
- Ensembl
- ENSG00000101213
- Chromosome
- 20
- Canonical length
- 451 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
451 residues, UniProt reviewed canonical sequence.
>Q13882|PTK6
1 MVSRDQAHLG PKYVGLWDFK SRTDEELSFR AGDVFHVARK EEQWWWATLL DEAGGAVAQG
61 YVPHNYLAER ETVESEPWFF GCISRSEAVR RLQAEGNATG AFLIRVSEKP SADYVLSVRD
121 TQAVRHYKIW RRAGGRLHLN EAVSFLSLPE LVNYHRAQSL SHGLRLAAPC RKHEPEPLPH
181 WDDWERPREE FTLCRKLGSG YFGEVFEGLW KDRVQVAIKV ISRDNLLHQQ MLQSEIQAMK
241 KLRHKHILAL YAVVSVGDPV YIITELMAKG SLLELLRDSD EKVLPVSELL DIAWQVAEGM
301 CYLESQNYIH RDLAARNILV GENTLCKVGD FGLARLIKED VYLSHDHNIP YKWTAPEALS
361 RGHYSTKSDV WSFGILLHEM FSRGQVPYPG MSNHEAFLRV DAGYRMPCPL ECPPSVHKLM
421 LTCWCRDPEQ RPCFKALRER LSSFTSYENP TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTK6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 104 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 104 nTPM
- skin: 51 nTPM
- vagina: 41 nTPM
- cervix: 34 nTPM
- duodenum: 27 nTPM
- stomach: 25 nTPM
Single-cell type
- esophageal apical cells: 774 nCPM
- esophageal suprabasal cells: 187 nCPM
- colonocytes: 137 nCPM
- enterocytes: 118 nCPM
- foveolar cells: 95 nCPM
- suprabasal keratinocytes: 78 nCPM
Immune cell
- myeloid DC: 1.3 nTPM
- classical monocyte: 0.7 nTPM
- intermediate monocyte: 0.5 nTPM
- MAIT T-cell: 0.5 nTPM
- basophil: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
Brain region
- white matter: 14 nTPM
- cerebellum: 9.7 nTPM
- cerebral cortex: 8.6 nTPM
- basal ganglia: 7.5 nTPM
- pons: 7.5 nTPM
- medulla oblongata: 7.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTK6.
Disease | ImmuneIEDB
Conditions an epitope on PTK6 was assayed in.
- multiple sclerosis B cell
- amyotrophic lateral sclerosis B cell
- neuromyelitis optica B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cell migration
- cell surface receptor protein tyrosine kinase signaling pathway
- cellular response to retinoic acid
- ERBB2 signaling pathway
- intestinal epithelial cell differentiation
- negative regulation of growth
- negative regulation of protein tyrosine kinase activity
- positive regulation of cell cycle
- positive regulation of DNA replication
- positive regulation of epidermal growth factor receptor signaling pathway
- positive regulation of neuron projection development
- positive regulation of receptor signaling pathway via JAK-STAT
- protein autophosphorylation
- protein phosphorylation
- tyrosine phosphorylation of STAT protein
Molecular functions
- ATP binding
- identical protein binding
- non-membrane spanning protein tyrosine kinase activity
- protein tyrosine kinase activity
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- SH2 domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- SH3-like domain superfamily
- SH2 domain superfamily
- Non-receptor tyrosine kinases involved in cell signaling
- SH2 domain
- SH3 domain
- Protein tyrosine and serine/threonine kinase
- PTK6, SH2 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTK6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTK6 as an antibody target. Whether an autoantibody or antibody against PTK6 could matter depends on whether native PTK6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTK6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTK6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...